Neozenith

Pharma Consultancy

What is Pharma Consultancy?

Pharma Consultancy provides assistance of product development in biotechnology, pharmaceutical and device fields. It is an affair of specialists that aims to advice and train nonclinical testing, clinical trial design, manufacturing, regulatory agency interactions, submission preparation and so on.

The Importance and Advantages of Pharma Consultancy

The Pharma Consultancy is important to ensure oncology growth by meeting the goals and making the most of the investment. It can help on market strategy where client will adopt the market trends to roll the company globally. It also helps on how to trim costs by focusing on investments and how to grow strategies.

Standards of Pharma Consultancy

The following services can be offered to Pharma and Cosmetic industry

Pharmaceutical Industry (API & Formulations)

  • Document & Data preparation assistance
  • Dossier/submission preparation or review and filing for various drug regulators worldwide.
  • Submission preparation to other worldwide agencies in European Countries, South America, Australia, and Asia
  • Consideration of international regulatory requirements
  • Meeting international filings
  • Revision of plans as guidelines change


Facilitate interaction with regulatory agencies, such as in meetings and conference calls, negotiations during development stages, submissions and submission approval process:

Help you respond to regulatory agency questions.

GMP Auditing 

  •  Preparation of your organization for USFDA/TGA/MHRA/MCC/ANVISA/EDQM etc. GMP audits by gap analysis, document preparation, site specific verification & guidance.
  • ICH Q7a Gap Assessment
  • Quality Risk management adequacy verification as per ICH Q9
  • Help you establish quality systems in line with ICH Q10


Cosmetic & Excipient Industry 

  •  EFfCI (European Federation for Cosmetic Ingredients)
  • ISO 22716:2007 Cosmetic cGMP compliance assistance
  • EXCiPACT implementation assistance
  • Gap audits and verification services to assist you in better system implementation
  • Pharma, cosmetic, and excipient industry supply chain management solutions


Neozenith Consulting Services: Consultancy and Assistance as per 21 CFR Part 210, Part 211

Neozenith consultants can help you with the complete Pharma Consultancy process from documentation, implementation, trainings, internal audits and USFDA Approvals.

The process basically encompasses

  1. Interacting with Consultants for Structures, HVAC to design as per USFDA requirements
  2. Support in identification of relevant suppliers of equipment.
  3. Identification of Validation requirements and completing validation in line with USFDA requirements
  4. Support in Product development and Commercialization in countries such as UAE, Singapore, Malaysia, UK, Romania, Qatar, Oman, Saudi Arabia, Yemen, Maldives, and Indonesia.
  5. Support in creation of Batch manufacturing record, Batch process records, Policies, Manuals, Standard operating procedures.
  6. Support in Electronic submission to FDA, Health Canada and other regulatory bodies.
  7. Support towards meeting compliance requirements
  8. Resolving issues related to contamination.

Regulatory - DMF

Drug Master File

Drug Master File (FDA DMF)

Drug Master File (FDA DMF) is a confidential document submitted voluntarily to the FDA by human drug manufacturers, processors, packagers, and stores. DMF contains information about production facilities, processes, packaging, quality control, and storage products. FDA DMF is generally submitted by manufacturers of Active Pharmaceutical Ingredient (API), Drug Substance, Drug Intermediate Substance, and Drug Packaging Material.

Drug master file usually contains the components/ingredients, chemistry, process technology, quality controls either of drug substance, excipient, or packaging material. Drug Master File has a significant role in finished product drug applicants’ NDAs, ANDAs, and INDs. So, careful preparation of files by an expert is highly essential for successful submission.

Drug Master File Types

Drug Master File TYPE I: Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable).
Drug Master File TYPE II: Drug products or substances or intermediate and or materials used for drug preparation.
Drug Master File TYPE III: Packaging Material.
Drug Master File TYPE IV: Excipient or Colorant or Flavour/Essence or material used in the Preparation.
Drug Master File TYPE V: FDA Accepted Reference Information.

Regional DMFs:

The DMFs generated for regions (excluding USA and Europe) are covered under Regional DMFs for the following countries: Canada, China, Turkey, Brazil, Korea, South Africa, Australia, Syria, and Saudi Arabia. Regional guidelines of the respective countries must be followed for generation and submission of the Regional Drug Master Files.

Regulatory - FDA

FOOD AND FACILITY REGISTRATION WITH FDA

FDA Registration

FDA registration is the basic requirement for domestic and foreign establishments that manufacture or market food, drug, API, medical devices, or cosmetic products in the USA. Companies that manufacture, process, pack, or store these products in the United States may be required to register with the FDA. Here are some examples of the types of companies that require FDA registration:

  • Food manufacturers, processors, and packers
  • Drug manufacturers, packers, and repackers
  • Medical device manufacturers and importers
  • Cosmetics manufacturers and processors

It’s important to note that the FDA has specific registration requirements for each type of product, and the registration requirements for all kinds of companies are not the same.

US FDA Agent

All foreign Establishments must identify a US FDA Agent while in the registration process. This is a mandatory requirement, and without US FDA Agent, the registration cannot be completed. Neozenith Consulting Services provides US FDA Agent service to foreign food, drug, API, and medical device establishments.

FDA Registration Renewal

All Drug, API, and Medical Device establishments registered with FDA must renew their registration annually between October 1st and December 31st. Food facilities must renew their FDA registration between October 1st and December 31st of every even-numbered year (once every 2 years). The FDA may consider the products of companies that do not comply with FDA renewal requirements as misbranded and may lead to FDA detention of your products.

FDA Certification

FDA Registration or FDA registration number does not denote FDA certification or FDA approval of your facility or products. Any representation of the FDA registration number on the product label or labeling which implies FDA certification or FDA approval of a facility or product is misleading and may cause misbranding of the product.

FDA Certificate

FDA will not issue a registration certificate after completing the registration; also, FDA will not recognize a third-party registration certificate. Most Importers and Shipping companies always ask for an FDA registration certificate or proof of FDA registration from the manufacturer.

FDA Registration Fees

Neozenith Consulting Services offers the most competitive fees for FDA registration, US FDA agent service, NDC number request, Drug listing, Label review, and other services.

About Us

Neozenith Consulting Services is a globally recognized FDA, CE Marking, and ISO consulting firm headquartered in Madhya Pradesh, India with Associates and offices around the globe. At NCS, we provide a full range of consulting services to domestic establishments in FDA regulations.

If you are looking for assistance in FDA regulations, FDA registration, or US FDA Agent requirements, NCS will be the best choice. Our dedicated and experienced consultants can provide exceptional guidance on US FDA regulations. We always give you an accurate estimate of the total cost involved in each project; we will never put you in uncertainty with hourly consulting fees. NCS provides quality service at a reasonable price within a minimum time frame.

Our mission is to provide maximum benefits to our clients through the proper guidance in FDA regulations and provide the latest information about the changes in FDA regulations

EFfCI Certification

EFFCI GMP Certification

EFfCI Certification

EFfCI was formed out of interest of over 100 cosmetic ingredients companies in Europe. The EFfCI published the Good Manufacturing Practice (GMP) Guide for Cosmetic Ingredients – Revision 2017, including the Certification Standard and Scheme for GMP for Cosmetic Ingredients. It is mandatory for companies in third world countries supplying ingredients to cosmetic manufacturing companies etc. to comply with the requirements and apply for certification.

The format of the EFfCI GMP Guidelines is based on the structure of ISO 9001 and the IPEC (International Pharmaceutical Excipients Council) GMP guide.
EFfCI GMP certification ensures compliance with good manufacturing practice in the production of cosmetic ingredients. It therefore guarantees that companies manufacturing cosmetic ingredients comply with regulations that ensure product quality in terms of both materials and production processes. It also enables cosmetics manufacturers to demonstrate compliance with ISO 22716: 2007 (Cosmetics – Good Manufacturing Practices guidelines) and EU Regulation (EC) No 1223/2009 on cosmetic products.

Good manufacturing practices for cosmetic ingredients. Reference EFfCI

The EFfCI certification scheme is aimed at companies that manufacture ingredients for use in cosmetic products, in order to ensure good practices in the preparation and manufacturing processes, before their distribution to consumers. 

Through this certification scheme, the safety of cosmetics is reinforced through a quality management system, while minimizing the costs of quality assessment within the supply chain. 

The group of cosmetic products also includes hygiene and health products, as well as personal care products (sunscreen, shampoo, soap, etc.). 

Good Manufacturing Practice (GMP) is the practical development of the quality assurance concept and is based on sound scientific judgment and risk assessments.

Benefits obtained: 

  • Guarantee that the organization complies with Good Manufacturing Practices according to the EFfCI reference.
  • Cost savings by reducing the burden of audits performed by cosmetic manufacturers.
  • Improve the levels of management, planning, organization and control.
  • Ensures the highest quality and safety of the cosmetic ingredients supplied.
  • Access to new markets through an internationally recognized certification scheme.


Neozenith EFfCI GMP Certification: Consultancy and Assistance:

Neozenith consultancy can help you with the complete EFfCI GMP Certification process from documentation, implementation, trainings, internal audits and right certification body.

EXCiPACT Certification

EXCiPACT Certification

Regulators require excipient users to qualify their suppliers based on GMP/GDP audits and they have indicated that third party auditing of suppliers is acceptable if a creditable certification body issues certificates and audit reports by employing qualified auditors who are demonstrably credible in suitable GMP/GDP standards and in the needs of the pharmaceutical industry. EXCiPACT assembly is a non-profit organisation that owns and manages oversight of such an independent, high quality, third party Certification Scheme available to pharmaceutical excipient manufacturers and distributors worldwide.

CERTIFICATION SCHEME

The Certification Scheme can only be undertaken by a Registered EXCiPACT Certification Body employing a Registered EXCiPACT Auditor. The certification process is summarised in the following eight steps:

Step 1

Supplier selects a Certification Body from the approved list and provides them with information to issue a cost quotation, audit timetable and duration for a 3-year certification audit. This reflects the supplier’s audit scope and the organisational and operational complexity of the specified site.

Step 2

Supplier and Certification Body sign an Agreement for a 3-year certification audit of a specified site that covers its scope, audit standard(s), audit duration, audit schedule, surveillance audits and an auditor from the approved list.

Step 3

Stage 1 Audit: Auditor reviews supplier’s on-site documentation against the audit standard(s) and writes to the supplier to identify nonconformities and agrees the time needed for them to be resolved before the Stage 2 detailed on-site audit commences.

Step 4

Stage 2 Audit: Auditor undertakes a full on-site site inspection against the audit standard(s) and submits a report to include any major nonconformities to the Certification Body’s Independent Certification Board (ICB) for review and a certification decision.

Step 5

ICB makes the certification decision and issues the certificate and audit report to the supplier. EXCiPACT issues an invoice to the supplier for the Certification Fee and on receipt adds the supplier’s details to the approved list of suppliers on their website and may issue a press release.

Step 6

The certificate is valid for 3 years and surveillance audits are held at least annually to address all Scheme requirements including inter alia internal audits, actions on previous nonconformities, complaints, and QMS effectiveness. Written reports are sent to the supplier after each audit.

Step 7

A recertification audit takes place at the supplier’s request before the date of expiration of the latest certificate to confirm the continued conformity to the current EXCiPACT standard(s).

Step 8

If the supplier makes any changes to the scope of their certificate, or to the management and ownership, or becomes aware of legal proceedings with respect to product safety or legality, or of a product recall, they must immediately inform the Certification Body who will take appropriate action.

Why EXCiPACT Certification?

  • Adds Value to the Pharmaceutical Industry
  • Provided by approved Third Party Certification Bodies
  • Third Party Certification can assist medicinal product manufacturers in achieving compliance with GMP and/or GDP Standards at reduced costs and impact on time and resource
  • Saves both Supplier and their Customers money
  • Reduces the number of audits and cost for Supplier and User(s)
  • Supported to key Regulatory Bodies
  • Helps excipient users identify qualified Suppliers
  • Patient Safety is Enhanced
  • More Robust than 1st/2nd Party Certification
  • Audit Reports based on unbiased, excipient GMP and/or GDP Practices
  • Allows Pharma Companies to redirect Internal Auditors to issue outside the GMP/GDP Standards’ Scopes
  • Regulatory Acceptance of accredited Third Party Audits for assessing Quality and Safety.


Who should get EXCiPACT Certification?

Pharmaceutical Excipient Manufacturers and Distributors.

How Neozenith Help you to get EXCiPACT Certification:

  • Gap analysis, review of the existing Quality Management System. This review is carried out through discussions and verifications of records during visits to the client organization. The pharma customer specific requirements are taken into consideration to make this activity effective.
  • GMP based system designing and documentation (Records and Procedures). 100% documentation support is offered by Neozenith. This includes shop floor controls as well as control on documentation and records.
  • Training on GMP and QMS related requirements
  • Routine assistance and system verification to ensure compliance to the requirements.
  • Internal audit and Management review
  • Certification audit – Stage 1 and Stage 2
  • Submission of action plan on audit observations
  • Review of report by the certification authority and awarding the certificate to the organization.

WHO - GMP

Good Manufacturing Practices

Good Manufacturing Practices

Good Manufacturing Practices (GMP, also referred to as ‘cGMP’ or ‘current Good Manufacturing Practice’) is the aspect of quality assurance that ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the product specification.

GMP defines quality measures for both production and quality control and defines general measures to ensure that processes necessary for production and testing are clearly defined, validated, reviewed, and documented, and that the personnel, premises and materials are suitable for the production of pharmaceuticals and biologicals including vaccines. GMP also has legal components, covering responsibilities for distribution, contract manufacturing and testing, and responses to product defects and complaints. Specific GMP requirements relevant to classes of products such as sterile pharmaceuticals or biological medicinal products are provided in a series of annexes to the general GMP requirements.

GMP Guidance

The first WHO draft text on GMP was adopted in 1968. In 1969, when the World Health Assembly recommended the first version of the WHO Certification Scheme on the quality of pharmaceutical products moving in the global market, it accepted the WHO GMP as an integral part of the Scheme. A supplementary annex on biological medicinal products was adopted by the Expert Committee on Biological Standardization (ECBS) in 1991 and establishes the general approach to the quality control of biological medicines that include products such as vaccines, blood and blood products, antigens, cell and tissue therapies, biopharmaceutical products, and others.

More than 100 countries have incorporated the WHO GMP provisions into their national medicines laws, and many more countries have adopted its provisions and approach in defining their own national GMP requirements. The WHO GMP continues to be used as a basis for the WHO Certification Scheme and prequalification of vaccines for procurement by UN agencies

Overview of GMP Certification

GMP stands for Good Manufacturing Practice, & the term is used globally for managing the control and management of manufacturing, testing and overall quality of pharmaceutical products. It defines certain guidelines that talks about the quality assurance approach. GMP certification ensures that products are produced following the quality standard norms.

Joint Commissioner is authorized by Commissioner, Food & Drug Administration, to sign & issue the certificates under the WHO-GMP certification scheme. GMP certification deals with issues like documentation, record keeping, personnel qualifications, sanitation, cleanliness, equipment verification, sanitation, complaint handling, and process validation.

GMP requirements are not peculiar in any sense instead they are open ended and easy to implement also these requirements give liberty to the manufacturer to decide individually how to efficiently implement the necessary controls.

What is the Purpose of Goods Manufacturing Practice?

The main purpose of Goods Manufacturing Practice is to reduce the amount of risk involved in the production of pharmaceutical items. Pharmaceutical items include risks such as: (a) unexpected uncleanness in the product can badly affect the health which can further lead to death; (b) incorrect labels on containers which simply implies that patient is consuming the wrong medicine, (c) too much active or too less ingredient, (d) causing ineffective treatment or adverse effects, etc.

GMP has many authority under it such as covering all aspects of production, from the starting material, details regarding areas and equipment to the training and personal hygiene of staff. It provides the complete details regarding the procedures that yield the finished product and could affect the quality of it.

What does GMP Guidelines Directs the Certification Holders?

WHO (World Health Organization) has formed certain guidelines for good manufacturing practices. Numerous nations have defined their own necessities for GMP based on WHO GMP. Others have fit their prerequisites, for instance in the Association of South-East Asian Nations (ASEAN), in the European Union and through the Pharmaceutical Inspection Convention.

GMP guidelines require a quality way to deal with manufacturing, empowering organizations to limit or eliminate instances of contamination, misunderstandings, and mistakes. This shields the consumer from buying an item which isn’t compelling or even risky.

Most GMP prerequisites are extremely extensive and open-ended, permitting every maker to choose independently how to best actualize the essential controls. This gives a lot of adaptability, yet additionally necessitates that the producer decipher the prerequisites in a way which makes sense for every individual business.

What are the Benefits of GMP Certification?

Every pharmaceutical and medical device manufacturers follow GMP rules and procedures while some have created their own guidelines that correspond with their legislation.

  • Empower certification holders to opt great creation,
  • Timely identify of manufactures and the management issues,
  • Compliance with important laws and guidelines,
  • Improve overall credibility and public image,
  • Reduce safety risk in product quality and safety,
  • Increases consumer confidence in your products,
  • Helps to decrease operating costs due to rework and penalties due to non-compliance,
  • Helps boost export opportunities,
  • Reduced duplication of inspections,
  • Cost saving.


Benefits for the Manufacturer

One of the primary benefits is significantly improved quality systems and quality compliance at the manufacturer. We have seen these improvements in the months leading up to GMP certification and continuing during the years immediately following GMP certification.

Benefits for the Customer

Customers will typically modify their oversight of manufacturers that have been GMP certified. Customers are aware that in order to be certified, the manufacturer must have systems in place and provide evidence that non-conformance and changes that require customer notification are handled appropriately. This assurance is typically not obtained through a one-day supplier audit that pharma companies carry out; rather, it is obtained as a result of thorough, multiple day audits of manufacturer as part of a certification audit program.

WHO - GDP

Good Distribution Purpose

Good Distribution Purpose

Neozenith Consulting Services is one of the largest and leading GDP consultants in India. We provide quick, result oriented and easy to implement consultation and training for GDP certificate. Whether you are a small organization or a multinational corporate, our proven consultation solutions will ensure that you implement GDP standard in the most effective manner with timely project completion.

GDP medicinal products distribution system implementation with the consultants and experts of Neozenith Consulting Services not only assures 100% successful GDP certification but also improves process performance and business operations.

Consultants of our organization assist your company in your medicinal distribution management context through GDP certification to get your company GDP certified quickly with ease of implementation and in the most cost effective manner.

We make sure that GDP standard implementation does not just become a documentation activity but also a way of life for the organization that lays a foundation for Total distribution Management and medicinal distribution conscious organizational culture.

We offer onsite and online consultation solutions for GDP certification. Our customers have been utilizing our services not only for initial certification consultation but also for post certification consultation to ensure that we regularly add value to their business processes of our customers and quality standardization initiatives.

Our GDP certificate consultation services include awareness training, medicinal product distribution management policy – objectives workshop, gap analysis, documentation design including manuals, procedures, work instructions, formats etc., implementation assistance & training, internal auditor training, lead auditor training, assistance in conducting internal audit, pre-assessment audit and everything required to ensure a 100% successful GDP certification audit within scheduled project completion time period.

Biggest benefit an organization gets out of GDP is improvement in business process control through process standardization. No matter what benefits you are looking for from GDP certification, we will make sure that your organization benefits from GDP implementation and certification.

What is GDP?

GDP is Good Distribution Purpose which is related to managing the distribution of medicinal products for human use. This standard helps us to maintain product safety and quality during distribution of pharmaceutical products.

Who can apply?

Organizations which are purchasing, receiving, storing and exporting drugs/medicines for human use can apply for this certification.

Benefits of implementing GDP:

  • Warehouse system is improved.
  • Distribution of pharmaceutical products is standardized and effectively improved
  • Product safety is achieved
  • Customer satisfaction is improved.
  • Quality of product is maintained during distribution.


Guidelines for distribution of medicinal products include:

  • Order
  • Procedure
  • Record
  • Premises and equipment
  • Receipt
  • Storage
  • Deliveries to customers
  • Return of non-defective medicinal products
  • Emergency plan and recalls
  • Counterfeit medicinal products
  • Special provisions concerning products classified as not for sale
  • Self-inspections
  • Provision of information to member states in relation to wholesale activity


What do we offer for GDP Certification for your organization?

We offer GDP training, implementation, consultation, gap analysis, documentation, internal audits, pre-assessment audits, certification audit through best of the certification bodies and post certification enhancement / maintenance services to enable your organization to get the best out of GDP management system. Our services are globally accepted, authoritative and benchmarked in the field of GDP.